Bristol-Myers adds three directors in deal with Jana Partners
Feb 21 Bristol-Myers Squibb Co said on Tuesday it appointed three directors to its board in a deal with activist investor Jana Partners LLC. Bob Bertolini, former Bausch & Lomb CFO, Matthew Emmens, former Vertex Pharmaceuticals Inc CEO, and Theodore Samuels, who is on the boards of Perrigo and Stamps.com, have been added to the board. Bristol-Myers, which also announced a $2 billion accelerated share repurchase program, said the appointments would temporarily increase the size of the board to 14. Feb 21 Minneapolis Federal Reserve Bank President Neel Kashkari on Tuesday said the U.S. labor market has "more room to run," suggesting he does not believe the central bank should raise rates quickly to head off inflation.
from Biotech News